Aviv A, Livne A
Hypertension Research Center, University of Medicine & Dentistry, Newark, New Jersey 07103-2757.
Am J Hypertens. 1988 Oct;1(4 Pt 1):410-3. doi: 10.1093/ajh/1.4.410.
We propose that in essential hypertension higher cytosolic free Ca2+ ([Ca2+]i) is associated with hyperactivity of the Na+/H+ antiport and that augmented activity of this transport system explains at least some abnormalities in Na+ metabolism associated with this disease. In low-renin essential hypertension, a higher [Ca2+]i is present not only in vascular smooth muscle cells of resistance vessels but also in juxtaglomerular cells and renal proximal tubular epithelium. A higher [Ca2+]i in juxtaglomerular cells retards renin secretion, whereas in renal proximal tubules it is associated with increased Na+ reabsorption via the Na+/H+ antiport. Thus, hyperactivity of the Na+/H+ antiport in renal tubular epithelium may be the cause of salt (NaCl) sensitivity. Ca2+ antagonists probably exert their antihypertensive effect by reducing [Ca2+]i in both vascular smooth muscle cells and renal tubular epithelium. These agents are, therefore, particularly effective in the treatment of essential hypertension in blacks and older individuals with the low-renin form of the disease, who are known to be salt sensitive.
我们提出,在原发性高血压中,较高的胞浆游离钙离子浓度([Ca2+]i)与Na+/H+逆向转运体的活性亢进有关,并且该转运系统活性的增强至少可以解释与该疾病相关的钠代谢异常中的一些情况。在低肾素性原发性高血压中,较高的[Ca2+]i不仅存在于阻力血管的血管平滑肌细胞中,还存在于肾小球旁细胞和肾近端小管上皮细胞中。肾小球旁细胞中较高的[Ca2+]i会抑制肾素分泌,而在肾近端小管中,它与通过Na+/H+逆向转运体增加的钠重吸收有关。因此,肾小管上皮细胞中Na+/H+逆向转运体的活性亢进可能是盐(NaCl)敏感性的原因。钙拮抗剂可能通过降低血管平滑肌细胞和肾小管上皮细胞中的[Ca2+]i来发挥其降压作用。因此,这些药物在治疗已知对盐敏感的黑人及低肾素型疾病的老年原发性高血压患者中特别有效。